By:
On:
In: Actions, Meetings

On Thursday March 8, 2018, the Union for Affordable Cancer Treatment delivered the following testimony at the hearing for the 2018 Special 301 list.  The testimony was delivered by Dr. Manon Ress. To see previous UACT written submissions and testimonies to the Special 301 review process, please visit our page on our work concerning the Office of the US Trade Representative. Prepared statement of UACT (PDF), for March 8, 2018 hearing on the USTR Special 301 list Docket No. USTR-2017-0024 My name is Manon Ress. I am speaking today on behalf of the Union for Affordable Cancer Treatment, which filed comments in this docket onRead More →

By:
On:
In: Actions

UACT has submitted comments to the United States Trade Representative regarding the 2018 Special 301 Review. UACT’s comments can be found as a pdf here and copied in full below:   1621 Connecticut Avenue NW Suite 500 Washington, DC 20009 Tel.: 202.332.2670 www.uact.org February 6, 2018 Sung Chang Director for Innovation and Intellectual Property United States Trade Representative Docket No. USTR-2017-0024 Via submissions made through the Federal eRulemaking Portal: http://www.regulations.gov. Dear Sung Chang, Re: UACT Comments Regarding the 2018 Special 301 Review The Union for Affordable Cancer Treatment (UACT), created in 2014, is a union of people affected by cancer, their family members and friends,Read More →